Unity Software's Q4 results show progress amid challenges. Learn about its AI ad tech, future growth prospects, and why 2025 ...
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)[1] and OXB,[2] today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
Apex Fusion releases the PRIME chain and the AP3X token, which combine Bitcoin's security with Ethereum's programmability.
Cisco AI Defense is purpose-built to address the security paradox AI creates with its exponential growth in enterprises ...
India has developed a novel antibiotic to fight antimicrobial resistance (AMR), as well as a new drug to tackle burden of ...
Trump has always been a wrecking ball, but now that he’s pummeling Big Tech’s perceived enemies, he’s become a hero to a ...
China's AS700D electric manned airship completed a successful maiden flight on Friday, marking a major breakthrough for ...
9h
GlobalData on MSNBoehringer and partners commence gene therapy trial for cystic fibrosisBoehringer Ingelheim, the UK Respiratory Gene Therapy Consortium (GTC), IP Group and Oxford BioMedica (OXB) have commenced ...
The AS700D, developed by the Special Vehicle Research Institute under AVIC, is a novel all-electric airship that features a comprehensive electrification upgrade from the AS700 manned airship, which ...
AccelerComm’s 5G NR NTN physical-layer approach employs devices with vector-processing cores for signal processing.
1st LD-Writethru-China Focus: China-developed AS700D electric manned airship completes maiden flight
BEIJING, Feb. 21 (Xinhua) -- China's AS700D electric manned airship completed a successful maiden flight on Friday, marking a major breakthrough for the country in green aviation equipment in the ...
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results